These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1832289)

  • 1. Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease--relation to plasma concentration.
    Mitrovic V; Petrovic O; Bahavar H; Neuzner J; Dieterich HA; Schlepper M
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):689-95. PubMed ID: 1832289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic, antiischemic, and neurohumoral effects of enoximone in patients with coronary artery disease.
    Mitrovic V; Thormann J; Neuzner J; Bahawar H; Volz M; Dieterich HA; Schlepper M
    Am Heart J; 1989 Jan; 117(1):106-11. PubMed ID: 2563185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Hamm C
    Herz; 2000 Mar; 25(2):130-42. PubMed ID: 10829253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic, anti-ischemic, metabolic and neurohumoral effects of enoximone (MDL 17,043) in patients with coronary disease].
    Mitrovic V; Schlepper M; Neuzner J; Bahavar H; Volz M; Dieterich HA
    Z Kardiol; 1988 Oct; 77(10):660-7. PubMed ID: 2977029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
    Gilbert EM; Bristow MR; Mason JW
    Am J Cardiol; 1987 Aug; 60(5):57C-62C. PubMed ID: 2956870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enoximone treatment of impaired myocardial function during cardiac surgery: combined effects with epinephrine.
    Boldt J; Kling D; Moosdorf R; Hempelmann G
    J Cardiothorac Anesth; 1990 Aug; 4(4):462-8. PubMed ID: 2151889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study.
    Leier CV; Lima JJ; Meiler SE; Unverferth DV
    Am Heart J; 1988 May; 115(5):1051-9. PubMed ID: 2966546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of intravenous milrinone in chronic symptomatic ischemic heart disease.
    Mitrovic V; Stöhring R; Schlepper M
    Am Heart J; 1991 Jun; 121(6 Pt 2):1983-94. PubMed ID: 1827940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dobutamine and enoximone for low output states following cardiac surgery.
    Orellano L; Darwisch M; Dieterich HA; Köllner V
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S13-9. PubMed ID: 2145233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions: the new phosphodiesterase inhibitor enoximone and the calcium channel blocker nifedipine in coronary surgery patients--influence on hemodynamics and plasma concentrations.
    Boldt J; Kling D; Dietevich HA; Hempelmann G
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):37-43. PubMed ID: 1688980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
    Gibelin P; Garraffo R; Sbirrazzuoli V; Lapalus P; Morand P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():75-81. PubMed ID: 2147839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
    Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA
    Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enoximone].
    Ventura G
    Medicina (Firenze); 1990; 10(2):191-3. PubMed ID: 2148796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients.
    Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S7-11. PubMed ID: 2145239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic effects of the new phosphodiesterase inhibitor enoximone in heart surgery patients].
    Boldt J; Kling D; Schuhmann E; Dapper F; Hempelmann G
    Anaesthesist; 1989 May; 38(5):238-44. PubMed ID: 2525351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F; Peters P; Schneider M
    Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT; Janicki JS; Jain MC
    J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition kinetics of orally administered enoximone in patients with moderate to severe heart failure.
    Ruder MA; Lebsack C; Winkle RA; Mead RH; Smith N; Kates RE
    J Clin Pharmacol; 1991 Aug; 31(8):702-8. PubMed ID: 1831816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure.
    Klauss V; Zwehl W; Mudra H; Huber R; Schmidt R; Scheininger M; Vogler A; Tschaidse O; Dieterich HA; Theisen K
    Klin Wochenschr; 1991 Jul; 69(10):430-5. PubMed ID: 1719270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of R80122. The influence of a new phosphodiesterase inhibitor on global and intestinal hemodynamics in coronary surgery patients].
    Lange H; Stephan H; Autschbach R; Lueerssen K; Zielmann S; Sonntag H
    Anaesthesist; 1992 Aug; 41(8):474-80. PubMed ID: 1524159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.